Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 338.95-157.4156.45-75.8944.49

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is 338.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025338.95
Mar2024-157.41
Mar202356.45
Mar2022-75.89
Mar202144.49

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 338.95
Positive
Mar2024 -157.41
Negative
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,580.9 Cr -3.3% -0.8% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,179.0 Cr 0.5% 6.8% 16.3% Stock Analytics
DIVIS LABORATORIES ₹196,095.0 Cr 0.6% 8.7% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,530.0 Cr 0.4% 13.8% 46.9% Stock Analytics
CIPLA ₹114,318.0 Cr -0.4% 5.8% -2.9% Stock Analytics
DR REDDYS LABORATORIES ₹98,742.1 Cr -1.9% -5.1% -2.2% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-3.3%

-0.8%

-15.3%

SENSEX

0.5%

0.1%

-6.1%


You may also like the below Video Courses